nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—ABCC2—Spironolactone—dilated cardiomyopathy	0.165	0.42	CbGbCtD
Doxorubicin—ABCC2—Furosemide—dilated cardiomyopathy	0.113	0.287	CbGbCtD
Doxorubicin—ABCB1—Lisinopril—dilated cardiomyopathy	0.0611	0.156	CbGbCtD
Doxorubicin—ABCB1—Spironolactone—dilated cardiomyopathy	0.0538	0.137	CbGbCtD
Doxorubicin—NOS3—pulmonary artery—dilated cardiomyopathy	0.0135	0.0935	CbGeAlD
Doxorubicin—AKR1A1—cardiac ventricle—dilated cardiomyopathy	0.00486	0.0337	CbGeAlD
Doxorubicin—AKR1A1—myocardium—dilated cardiomyopathy	0.00457	0.0317	CbGeAlD
Doxorubicin—NDUFS7—cardiac ventricle—dilated cardiomyopathy	0.00442	0.0307	CbGeAlD
Doxorubicin—ABCB8—heart—dilated cardiomyopathy	0.00429	0.0298	CbGeAlD
Doxorubicin—NDUFS7—myocardium—dilated cardiomyopathy	0.00416	0.0288	CbGeAlD
Doxorubicin—CBR3—heart—dilated cardiomyopathy	0.00413	0.0287	CbGeAlD
Doxorubicin—AURKA—myocardium—dilated cardiomyopathy	0.00386	0.0268	CbGeAlD
Doxorubicin—NDUFS2—cardiac ventricle—dilated cardiomyopathy	0.00366	0.0254	CbGeAlD
Doxorubicin—NDUFS3—cardiac ventricle—dilated cardiomyopathy	0.00362	0.0251	CbGeAlD
Doxorubicin—NDUFS2—myocardium—dilated cardiomyopathy	0.00344	0.0239	CbGeAlD
Doxorubicin—NDUFS3—myocardium—dilated cardiomyopathy	0.0034	0.0236	CbGeAlD
Doxorubicin—AKR1A1—heart—dilated cardiomyopathy	0.00319	0.0222	CbGeAlD
Doxorubicin—YWHAG—cardiac ventricle—dilated cardiomyopathy	0.00315	0.0219	CbGeAlD
Doxorubicin—YWHAG—myocardium—dilated cardiomyopathy	0.00297	0.0206	CbGeAlD
Doxorubicin—NDUFS7—heart—dilated cardiomyopathy	0.0029	0.0201	CbGeAlD
Doxorubicin—RALBP1—cardiac ventricle—dilated cardiomyopathy	0.00285	0.0198	CbGeAlD
Doxorubicin—NOS3—cardiac ventricle—dilated cardiomyopathy	0.0028	0.0194	CbGeAlD
Doxorubicin—AKR1A1—cardiac atrium—dilated cardiomyopathy	0.00273	0.0189	CbGeAlD
Doxorubicin—AURKA—heart—dilated cardiomyopathy	0.0027	0.0187	CbGeAlD
Doxorubicin—RALBP1—myocardium—dilated cardiomyopathy	0.00268	0.0186	CbGeAlD
Doxorubicin—NOS3—myocardium—dilated cardiomyopathy	0.00263	0.0183	CbGeAlD
Doxorubicin—AKR1C3—cardiac ventricle—dilated cardiomyopathy	0.00263	0.0182	CbGeAlD
Doxorubicin—CBR1—myocardium—dilated cardiomyopathy	0.0025	0.0174	CbGeAlD
Doxorubicin—NDUFS7—cardiac atrium—dilated cardiomyopathy	0.00248	0.0172	CbGeAlD
Doxorubicin—AKR1C3—myocardium—dilated cardiomyopathy	0.00247	0.0171	CbGeAlD
Doxorubicin—NOS1—heart—dilated cardiomyopathy	0.00242	0.0168	CbGeAlD
Doxorubicin—NDUFS2—heart—dilated cardiomyopathy	0.0024	0.0167	CbGeAlD
Doxorubicin—NDUFS3—heart—dilated cardiomyopathy	0.00237	0.0165	CbGeAlD
Doxorubicin—DHCR7—heart—dilated cardiomyopathy	0.00226	0.0157	CbGeAlD
Doxorubicin—POR—myocardium—dilated cardiomyopathy	0.00225	0.0157	CbGeAlD
Doxorubicin—YWHAG—heart—dilated cardiomyopathy	0.00207	0.0144	CbGeAlD
Doxorubicin—NDUFS2—cardiac atrium—dilated cardiomyopathy	0.00206	0.0143	CbGeAlD
Doxorubicin—NDUFS3—cardiac atrium—dilated cardiomyopathy	0.00203	0.0141	CbGeAlD
Doxorubicin—DHCR7—cardiac atrium—dilated cardiomyopathy	0.00193	0.0134	CbGeAlD
Doxorubicin—ABCC10—cardiac ventricle—dilated cardiomyopathy	0.0019	0.0132	CbGeAlD
Doxorubicin—RALBP1—heart—dilated cardiomyopathy	0.00187	0.013	CbGeAlD
Doxorubicin—NOS3—heart—dilated cardiomyopathy	0.00184	0.0128	CbGeAlD
Doxorubicin—YWHAG—cardiac atrium—dilated cardiomyopathy	0.00177	0.0123	CbGeAlD
Doxorubicin—CBR1—heart—dilated cardiomyopathy	0.00175	0.0121	CbGeAlD
Doxorubicin—AKR1C3—heart—dilated cardiomyopathy	0.00172	0.012	CbGeAlD
Doxorubicin—TOP2A—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.00166	1	CbGdCrCtD
Doxorubicin—RALBP1—cardiac atrium—dilated cardiomyopathy	0.0016	0.0111	CbGeAlD
Doxorubicin—POR—heart—dilated cardiomyopathy	0.00157	0.0109	CbGeAlD
Doxorubicin—CBR1—cardiac atrium—dilated cardiomyopathy	0.00149	0.0104	CbGeAlD
Doxorubicin—AKR1C3—cardiac atrium—dilated cardiomyopathy	0.00147	0.0102	CbGeAlD
Doxorubicin—NQO1—heart—dilated cardiomyopathy	0.0014	0.00971	CbGeAlD
Doxorubicin—POR—cardiac atrium—dilated cardiomyopathy	0.00135	0.00934	CbGeAlD
Doxorubicin—ABCC1—myocardium—dilated cardiomyopathy	0.00127	0.00878	CbGeAlD
Doxorubicin—ABCC10—heart—dilated cardiomyopathy	0.00125	0.00867	CbGeAlD
Doxorubicin—ABCC10—cardiac atrium—dilated cardiomyopathy	0.00107	0.00741	CbGeAlD
Doxorubicin—CYP1B1—heart—dilated cardiomyopathy	0.000982	0.00682	CbGeAlD
Doxorubicin—Viral infection—Lisinopril—dilated cardiomyopathy	0.000976	0.00433	CcSEcCtD
Doxorubicin—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000976	0.00433	CcSEcCtD
Doxorubicin—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000971	0.00431	CcSEcCtD
Doxorubicin—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000969	0.0043	CcSEcCtD
Doxorubicin—Cough increased—Lisinopril—dilated cardiomyopathy	0.000963	0.00427	CcSEcCtD
Doxorubicin—Alopecia—Spironolactone—dilated cardiomyopathy	0.000958	0.00425	CcSEcCtD
Doxorubicin—Oliguria—Lisinopril—dilated cardiomyopathy	0.000956	0.00424	CcSEcCtD
Doxorubicin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000953	0.00423	CcSEcCtD
Doxorubicin—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000926	0.00411	CcSEcCtD
Doxorubicin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000907	0.00403	CcSEcCtD
Doxorubicin—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000904	0.00401	CcSEcCtD
Doxorubicin—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000892	0.00396	CcSEcCtD
Doxorubicin—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000892	0.00396	CcSEcCtD
Doxorubicin—Neck pain—Lisinopril—dilated cardiomyopathy	0.000892	0.00396	CcSEcCtD
Doxorubicin—Purpura—Furosemide—dilated cardiomyopathy	0.000885	0.00393	CcSEcCtD
Doxorubicin—ABCC1—heart—dilated cardiomyopathy	0.000883	0.00613	CbGeAlD
Doxorubicin—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000881	0.00391	CcSEcCtD
Doxorubicin—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000881	0.00391	CcSEcCtD
Doxorubicin—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000881	0.00391	CcSEcCtD
Doxorubicin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000876	0.00389	CcSEcCtD
Doxorubicin—Lethargy—Furosemide—dilated cardiomyopathy	0.00087	0.00386	CcSEcCtD
Doxorubicin—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000866	0.00384	CcSEcCtD
Doxorubicin—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000861	0.00382	CcSEcCtD
Doxorubicin—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000856	0.0038	CcSEcCtD
Doxorubicin—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.000856	0.0038	CcSEcCtD
Doxorubicin—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.000856	0.0038	CcSEcCtD
Doxorubicin—Malaise—Spironolactone—dilated cardiomyopathy	0.000851	0.00378	CcSEcCtD
Doxorubicin—Cystitis—Lisinopril—dilated cardiomyopathy	0.000851	0.00378	CcSEcCtD
Doxorubicin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000845	0.00375	CcSEcCtD
Doxorubicin—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000837	0.00371	CcSEcCtD
Doxorubicin—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000832	0.00369	CcSEcCtD
Doxorubicin—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000827	0.00367	CcSEcCtD
Doxorubicin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000799	0.00354	CcSEcCtD
Doxorubicin—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000797	0.00354	CcSEcCtD
Doxorubicin—Discomfort—Spironolactone—dilated cardiomyopathy	0.000794	0.00352	CcSEcCtD
Doxorubicin—Dehydration—Furosemide—dilated cardiomyopathy	0.000793	0.00352	CcSEcCtD
Doxorubicin—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000784	0.00348	CcSEcCtD
Doxorubicin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000779	0.00346	CcSEcCtD
Doxorubicin—Confusional state—Spironolactone—dilated cardiomyopathy	0.000777	0.00345	CcSEcCtD
Doxorubicin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000776	0.00344	CcSEcCtD
Doxorubicin—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000773	0.00343	CcSEcCtD
Doxorubicin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00077	0.00342	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000768	0.00341	CcSEcCtD
Doxorubicin—ABCC1—cardiac atrium—dilated cardiomyopathy	0.000755	0.00524	CbGeAlD
Doxorubicin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000754	0.00335	CcSEcCtD
Doxorubicin—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000752	0.00334	CcSEcCtD
Doxorubicin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000742	0.00329	CcSEcCtD
Doxorubicin—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000735	0.00326	CcSEcCtD
Doxorubicin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000732	0.00325	CcSEcCtD
Doxorubicin—ABCG2—heart—dilated cardiomyopathy	0.000731	0.00508	CbGeAlD
Doxorubicin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00073	0.00324	CcSEcCtD
Doxorubicin—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000729	0.00323	CcSEcCtD
Doxorubicin—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000722	0.00321	CcSEcCtD
Doxorubicin—Eczema—Lisinopril—dilated cardiomyopathy	0.000712	0.00316	CcSEcCtD
Doxorubicin—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000712	0.00316	CcSEcCtD
Doxorubicin—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000693	0.00308	CcSEcCtD
Doxorubicin—Somnolence—Spironolactone—dilated cardiomyopathy	0.000685	0.00304	CcSEcCtD
Doxorubicin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000681	0.00302	CcSEcCtD
Doxorubicin—CYP2B6—heart—dilated cardiomyopathy	0.000675	0.00468	CbGeAlD
Doxorubicin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000673	0.00299	CcSEcCtD
Doxorubicin—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000672	0.00298	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000665	0.00295	CcSEcCtD
Doxorubicin—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000665	0.00295	CcSEcCtD
Doxorubicin—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000661	0.00293	CcSEcCtD
Doxorubicin—Drowsiness—Furosemide—dilated cardiomyopathy	0.000657	0.00292	CcSEcCtD
Doxorubicin—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000656	0.00291	CcSEcCtD
Doxorubicin—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000653	0.0029	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000651	0.00289	CcSEcCtD
Doxorubicin—Renal failure—Furosemide—dilated cardiomyopathy	0.000646	0.00287	CcSEcCtD
Doxorubicin—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000642	0.00285	CcSEcCtD
Doxorubicin—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00064	0.00284	CcSEcCtD
Doxorubicin—Diplopia—Lisinopril—dilated cardiomyopathy	0.00064	0.00284	CcSEcCtD
Doxorubicin—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00064	0.00284	CcSEcCtD
Doxorubicin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000635	0.00282	CcSEcCtD
Doxorubicin—Sweating—Furosemide—dilated cardiomyopathy	0.00063	0.0028	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000621	0.00276	CcSEcCtD
Doxorubicin—Face oedema—Lisinopril—dilated cardiomyopathy	0.000618	0.00274	CcSEcCtD
Doxorubicin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000613	0.00272	CcSEcCtD
Doxorubicin—Urticaria—Spironolactone—dilated cardiomyopathy	0.000612	0.00272	CcSEcCtD
Doxorubicin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000609	0.0027	CcSEcCtD
Doxorubicin—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000608	0.0027	CcSEcCtD
Doxorubicin—Ataxia—Lisinopril—dilated cardiomyopathy	0.000602	0.00267	CcSEcCtD
Doxorubicin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000599	0.00266	CcSEcCtD
Doxorubicin—Dehydration—Lisinopril—dilated cardiomyopathy	0.000595	0.00264	CcSEcCtD
Doxorubicin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000584	0.00259	CcSEcCtD
Doxorubicin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000583	0.00259	CcSEcCtD
Doxorubicin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000578	0.00257	CcSEcCtD
Doxorubicin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000578	0.00257	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000576	0.00256	CcSEcCtD
Doxorubicin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000572	0.00254	CcSEcCtD
Doxorubicin—Visual impairment—Furosemide—dilated cardiomyopathy	0.000568	0.00252	CcSEcCtD
Doxorubicin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000567	0.00252	CcSEcCtD
Doxorubicin—Gastritis—Lisinopril—dilated cardiomyopathy	0.000566	0.00251	CcSEcCtD
Doxorubicin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000558	0.00248	CcSEcCtD
Doxorubicin—Asthma—Lisinopril—dilated cardiomyopathy	0.000553	0.00245	CcSEcCtD
Doxorubicin—Influenza—Lisinopril—dilated cardiomyopathy	0.000553	0.00245	CcSEcCtD
Doxorubicin—Eye disorder—Furosemide—dilated cardiomyopathy	0.000551	0.00245	CcSEcCtD
Doxorubicin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00055	0.00244	CcSEcCtD
Doxorubicin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000547	0.00243	CcSEcCtD
Doxorubicin—Pruritus—Spironolactone—dilated cardiomyopathy	0.000545	0.00242	CcSEcCtD
Doxorubicin—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000542	0.00241	CcSEcCtD
Doxorubicin—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000539	0.00239	CcSEcCtD
Doxorubicin—Angiopathy—Furosemide—dilated cardiomyopathy	0.000535	0.00237	CcSEcCtD
Doxorubicin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000533	0.00236	CcSEcCtD
Doxorubicin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000532	0.00236	CcSEcCtD
Doxorubicin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000527	0.00234	CcSEcCtD
Doxorubicin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000527	0.00234	CcSEcCtD
Doxorubicin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000525	0.00233	CcSEcCtD
Doxorubicin—Dysuria—Lisinopril—dilated cardiomyopathy	0.000517	0.00229	CcSEcCtD
Doxorubicin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000517	0.00229	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000514	0.00228	CcSEcCtD
Doxorubicin—Malnutrition—Furosemide—dilated cardiomyopathy	0.000513	0.00228	CcSEcCtD
Doxorubicin—Erythema—Furosemide—dilated cardiomyopathy	0.000513	0.00228	CcSEcCtD
Doxorubicin—Dizziness—Spironolactone—dilated cardiomyopathy	0.000509	0.00226	CcSEcCtD
Doxorubicin—Flatulence—Furosemide—dilated cardiomyopathy	0.000506	0.00225	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000505	0.00224	CcSEcCtD
Doxorubicin—Weight increased—Lisinopril—dilated cardiomyopathy	0.000503	0.00223	CcSEcCtD
Doxorubicin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000503	0.00223	CcSEcCtD
Doxorubicin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.0005	0.00222	CcSEcCtD
Doxorubicin—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000499	0.00221	CcSEcCtD
Doxorubicin—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000496	0.0022	CcSEcCtD
Doxorubicin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000494	0.00219	CcSEcCtD
Doxorubicin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00049	0.00217	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000489	0.00217	CcSEcCtD
Doxorubicin—Rash—Spironolactone—dilated cardiomyopathy	0.000486	0.00216	CcSEcCtD
Doxorubicin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000485	0.00215	CcSEcCtD
Doxorubicin—Renal failure—Lisinopril—dilated cardiomyopathy	0.000485	0.00215	CcSEcCtD
Doxorubicin—Vision blurred—Furosemide—dilated cardiomyopathy	0.000484	0.00215	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000483	0.00214	CcSEcCtD
Doxorubicin—Headache—Spironolactone—dilated cardiomyopathy	0.000483	0.00214	CcSEcCtD
Doxorubicin—Jaundice—Lisinopril—dilated cardiomyopathy	0.000481	0.00213	CcSEcCtD
Doxorubicin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000479	0.00213	CcSEcCtD
Doxorubicin—Anaemia—Furosemide—dilated cardiomyopathy	0.000475	0.00211	CcSEcCtD
Doxorubicin—Sweating—Lisinopril—dilated cardiomyopathy	0.000473	0.0021	CcSEcCtD
Doxorubicin—Agitation—Furosemide—dilated cardiomyopathy	0.000472	0.00209	CcSEcCtD
Doxorubicin—Haematuria—Lisinopril—dilated cardiomyopathy	0.00047	0.00209	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000466	0.00207	CcSEcCtD
Doxorubicin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000465	0.00206	CcSEcCtD
Doxorubicin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000463	0.00205	CcSEcCtD
Doxorubicin—Vertigo—Furosemide—dilated cardiomyopathy	0.000461	0.00205	CcSEcCtD
Doxorubicin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00046	0.00204	CcSEcCtD
Doxorubicin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00046	0.00204	CcSEcCtD
Doxorubicin—Nausea—Spironolactone—dilated cardiomyopathy	0.000458	0.00203	CcSEcCtD
Doxorubicin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000451	0.002	CcSEcCtD
Doxorubicin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000444	0.00197	CcSEcCtD
Doxorubicin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000443	0.00196	CcSEcCtD
Doxorubicin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000439	0.00195	CcSEcCtD
Doxorubicin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000437	0.00194	CcSEcCtD
Doxorubicin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000436	0.00193	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000434	0.00193	CcSEcCtD
Doxorubicin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000434	0.00193	CcSEcCtD
Doxorubicin—Dry mouth—Furosemide—dilated cardiomyopathy	0.000428	0.0019	CcSEcCtD
Doxorubicin—Confusional state—Furosemide—dilated cardiomyopathy	0.000423	0.00188	CcSEcCtD
Doxorubicin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000419	0.00186	CcSEcCtD
Doxorubicin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000418	0.00186	CcSEcCtD
Doxorubicin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000413	0.00183	CcSEcCtD
Doxorubicin—Shock—Furosemide—dilated cardiomyopathy	0.000412	0.00183	CcSEcCtD
Doxorubicin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000411	0.00182	CcSEcCtD
Doxorubicin—Flushing—Lisinopril—dilated cardiomyopathy	0.000411	0.00182	CcSEcCtD
Doxorubicin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00041	0.00182	CcSEcCtD
Doxorubicin—Skin disorder—Furosemide—dilated cardiomyopathy	0.000407	0.00181	CcSEcCtD
Doxorubicin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000405	0.0018	CcSEcCtD
Doxorubicin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000402	0.00178	CcSEcCtD
Doxorubicin—Anorexia—Furosemide—dilated cardiomyopathy	0.000399	0.00177	CcSEcCtD
Doxorubicin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000399	0.00177	CcSEcCtD
Doxorubicin—Chills—Lisinopril—dilated cardiomyopathy	0.000397	0.00176	CcSEcCtD
Doxorubicin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000395	0.00175	CcSEcCtD
Doxorubicin—Hypotension—Furosemide—dilated cardiomyopathy	0.000392	0.00174	CcSEcCtD
Doxorubicin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000391	0.00174	CcSEcCtD
Doxorubicin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000388	0.00172	CcSEcCtD
Doxorubicin—Erythema—Lisinopril—dilated cardiomyopathy	0.000385	0.00171	CcSEcCtD
Doxorubicin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000385	0.00171	CcSEcCtD
Doxorubicin—Flatulence—Lisinopril—dilated cardiomyopathy	0.00038	0.00168	CcSEcCtD
Doxorubicin—Tension—Lisinopril—dilated cardiomyopathy	0.000378	0.00168	CcSEcCtD
Doxorubicin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000377	0.00167	CcSEcCtD
Doxorubicin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000376	0.00167	CcSEcCtD
Doxorubicin—Nervousness—Lisinopril—dilated cardiomyopathy	0.000374	0.00166	CcSEcCtD
Doxorubicin—Back pain—Lisinopril—dilated cardiomyopathy	0.000373	0.00165	CcSEcCtD
Doxorubicin—Somnolence—Furosemide—dilated cardiomyopathy	0.000373	0.00165	CcSEcCtD
Doxorubicin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00037	0.00164	CcSEcCtD
Doxorubicin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000364	0.00162	CcSEcCtD
Doxorubicin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000363	0.00161	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000362	0.00161	CcSEcCtD
Doxorubicin—Fatigue—Furosemide—dilated cardiomyopathy	0.000361	0.0016	CcSEcCtD
Doxorubicin—ABCB1—heart—dilated cardiomyopathy	0.000361	0.0025	CbGeAlD
Doxorubicin—Pain—Furosemide—dilated cardiomyopathy	0.000358	0.00159	CcSEcCtD
Doxorubicin—Constipation—Furosemide—dilated cardiomyopathy	0.000358	0.00159	CcSEcCtD
Doxorubicin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000357	0.00159	CcSEcCtD
Doxorubicin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000356	0.00158	CcSEcCtD
Doxorubicin—Malaise—Lisinopril—dilated cardiomyopathy	0.000347	0.00154	CcSEcCtD
Doxorubicin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000346	0.00154	CcSEcCtD
Doxorubicin—Syncope—Lisinopril—dilated cardiomyopathy	0.000345	0.00153	CcSEcCtD
Doxorubicin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000345	0.00153	CcSEcCtD
Doxorubicin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000345	0.00153	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000343	0.00152	CcSEcCtD
Doxorubicin—Palpitations—Lisinopril—dilated cardiomyopathy	0.00034	0.00151	CcSEcCtD
Doxorubicin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000339	0.0015	CcSEcCtD
Doxorubicin—Cough—Lisinopril—dilated cardiomyopathy	0.000336	0.00149	CcSEcCtD
Doxorubicin—Urticaria—Furosemide—dilated cardiomyopathy	0.000333	0.00148	CcSEcCtD
Doxorubicin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000331	0.00147	CcSEcCtD
Doxorubicin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000331	0.00147	CcSEcCtD
Doxorubicin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000328	0.00146	CcSEcCtD
Doxorubicin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000328	0.00146	CcSEcCtD
Doxorubicin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000328	0.00146	CcSEcCtD
Doxorubicin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000327	0.00145	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000326	0.00145	CcSEcCtD
Doxorubicin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000324	0.00144	CcSEcCtD
Doxorubicin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000321	0.00142	CcSEcCtD
Doxorubicin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000317	0.00141	CcSEcCtD
Doxorubicin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000314	0.0014	CcSEcCtD
Doxorubicin—Oedema—Lisinopril—dilated cardiomyopathy	0.000314	0.0014	CcSEcCtD
Doxorubicin—Infection—Lisinopril—dilated cardiomyopathy	0.000312	0.00139	CcSEcCtD
Doxorubicin—Shock—Lisinopril—dilated cardiomyopathy	0.000309	0.00137	CcSEcCtD
Doxorubicin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000309	0.00137	CcSEcCtD
Doxorubicin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000308	0.00137	CcSEcCtD
Doxorubicin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000307	0.00136	CcSEcCtD
Doxorubicin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000305	0.00136	CcSEcCtD
Doxorubicin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000304	0.00135	CcSEcCtD
Doxorubicin—Asthenia—Furosemide—dilated cardiomyopathy	0.000301	0.00133	CcSEcCtD
Doxorubicin—Anorexia—Lisinopril—dilated cardiomyopathy	0.0003	0.00133	CcSEcCtD
Doxorubicin—Pruritus—Furosemide—dilated cardiomyopathy	0.000296	0.00132	CcSEcCtD
Doxorubicin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000294	0.0013	CcSEcCtD
Doxorubicin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000287	0.00127	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000286	0.00127	CcSEcCtD
Doxorubicin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000284	0.00126	CcSEcCtD
Doxorubicin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000282	0.00125	CcSEcCtD
Doxorubicin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00028	0.00124	CcSEcCtD
Doxorubicin—Somnolence—Lisinopril—dilated cardiomyopathy	0.00028	0.00124	CcSEcCtD
Doxorubicin—Dizziness—Furosemide—dilated cardiomyopathy	0.000277	0.00123	CcSEcCtD
Doxorubicin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000277	0.00123	CcSEcCtD
Doxorubicin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000273	0.00121	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000271	0.0012	CcSEcCtD
Doxorubicin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000271	0.0012	CcSEcCtD
Doxorubicin—Pain—Lisinopril—dilated cardiomyopathy	0.000269	0.00119	CcSEcCtD
Doxorubicin—Constipation—Lisinopril—dilated cardiomyopathy	0.000269	0.00119	CcSEcCtD
Doxorubicin—Vomiting—Furosemide—dilated cardiomyopathy	0.000266	0.00118	CcSEcCtD
Doxorubicin—Rash—Furosemide—dilated cardiomyopathy	0.000264	0.00117	CcSEcCtD
Doxorubicin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000264	0.00117	CcSEcCtD
Doxorubicin—Headache—Furosemide—dilated cardiomyopathy	0.000263	0.00117	CcSEcCtD
Doxorubicin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000259	0.00115	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000257	0.00114	CcSEcCtD
Doxorubicin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00025	0.00111	CcSEcCtD
Doxorubicin—Nausea—Furosemide—dilated cardiomyopathy	0.000249	0.0011	CcSEcCtD
Doxorubicin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000249	0.0011	CcSEcCtD
Doxorubicin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000249	0.0011	CcSEcCtD
Doxorubicin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000232	0.00103	CcSEcCtD
Doxorubicin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000226	0.001	CcSEcCtD
Doxorubicin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000222	0.000987	CcSEcCtD
Doxorubicin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000215	0.000955	CcSEcCtD
Doxorubicin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000208	0.000923	CcSEcCtD
Doxorubicin—Vomiting—Lisinopril—dilated cardiomyopathy	0.0002	0.000887	CcSEcCtD
Doxorubicin—Rash—Lisinopril—dilated cardiomyopathy	0.000198	0.00088	CcSEcCtD
Doxorubicin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000198	0.000879	CcSEcCtD
Doxorubicin—Headache—Lisinopril—dilated cardiomyopathy	0.000197	0.000874	CcSEcCtD
Doxorubicin—Nausea—Lisinopril—dilated cardiomyopathy	0.000187	0.000829	CcSEcCtD
Doxorubicin—NQO1—Metabolism—TAZ—dilated cardiomyopathy	0.000138	0.000583	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000137	0.000582	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000137	0.000582	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000136	0.000575	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.000135	0.000573	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—TAZ—dilated cardiomyopathy	0.000133	0.000562	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—ITGB1—dilated cardiomyopathy	0.000133	0.000561	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ANKRD1—dilated cardiomyopathy	0.000131	0.000556	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00013	0.000551	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—LMNA—dilated cardiomyopathy	0.000129	0.000548	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000129	0.000546	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000128	0.000541	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000127	0.000537	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000127	0.000536	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—EGFR—dilated cardiomyopathy	0.000126	0.000532	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—SDHA—dilated cardiomyopathy	0.000125	0.000527	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.000124	0.000525	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—TAZ—dilated cardiomyopathy	0.000124	0.000523	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.000123	0.000522	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000122	0.000518	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000122	0.000517	CbGpPWpGaD
Doxorubicin—XDH—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000121	0.00051	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—SDHA—dilated cardiomyopathy	0.00012	0.000509	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00012	0.000507	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000119	0.000505	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000117	0.000497	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	0.000117	0.000496	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000117	0.000496	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000114	0.000483	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000114	0.000482	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000114	0.000482	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—CD36—dilated cardiomyopathy	0.000113	0.000479	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—TAZ—dilated cardiomyopathy	0.000112	0.000475	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000112	0.000474	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—SDHA—dilated cardiomyopathy	0.000112	0.000473	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000112	0.000472	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000111	0.000469	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TMPO—dilated cardiomyopathy	0.00011	0.000467	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000109	0.000461	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000109	0.000461	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000109	0.00046	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000109	0.00046	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000108	0.000459	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000108	0.000459	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000108	0.000456	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000108	0.000456	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—RAC1—dilated cardiomyopathy	0.000107	0.000451	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NPPA—dilated cardiomyopathy	0.000106	0.000449	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000103	0.000436	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PSEN2—dilated cardiomyopathy	0.000103	0.000434	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—SDHA—dilated cardiomyopathy	0.000102	0.00043	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000101	0.000429	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000101	0.000429	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0001	0.000424	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—ITGB1—dilated cardiomyopathy	0.0001	0.000423	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.74e-05	0.000412	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ANKRD1—dilated cardiomyopathy	9.69e-05	0.00041	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.47e-05	0.000401	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.47e-05	0.000401	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	9.29e-05	0.000393	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—TAZ—dilated cardiomyopathy	9.11e-05	0.000385	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	9.1e-05	0.000385	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—LMNA—dilated cardiomyopathy	9.06e-05	0.000383	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.99e-05	0.000381	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.81e-05	0.000373	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—TNF—dilated cardiomyopathy	8.77e-05	0.000371	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	8.73e-05	0.00037	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	8.72e-05	0.000369	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—CD36—dilated cardiomyopathy	8.53e-05	0.000361	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	8.46e-05	0.000358	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SDHA—dilated cardiomyopathy	8.24e-05	0.000349	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.23e-05	0.000348	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	8.16e-05	0.000345	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—RAC1—dilated cardiomyopathy	8.04e-05	0.00034	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NPPA—dilated cardiomyopathy	7.99e-05	0.000338	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.98e-05	0.000338	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.98e-05	0.000338	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	7.95e-05	0.000336	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	7.9e-05	0.000334	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GPX1—dilated cardiomyopathy	7.77e-05	0.000329	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—GPX1—dilated cardiomyopathy	7.77e-05	0.000329	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—ITGB1—dilated cardiomyopathy	7.77e-05	0.000329	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PSEN2—dilated cardiomyopathy	7.74e-05	0.000328	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CD36—dilated cardiomyopathy	7.57e-05	0.00032	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CD36—dilated cardiomyopathy	7.57e-05	0.00032	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.42e-05	0.000314	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NPPA—dilated cardiomyopathy	7.34e-05	0.000311	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.33e-05	0.00031	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—GPX1—dilated cardiomyopathy	7.31e-05	0.000309	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	7.28e-05	0.000308	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.2e-05	0.000305	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.19e-05	0.000304	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.14e-05	0.000302	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CD36—dilated cardiomyopathy	7.12e-05	0.000301	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PSEN2—dilated cardiomyopathy	7.11e-05	0.000301	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—RAF1—dilated cardiomyopathy	7.07e-05	0.000299	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	7.06e-05	0.000299	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	7.04e-05	0.000298	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	6.84e-05	0.00029	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AGT—dilated cardiomyopathy	6.82e-05	0.000289	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—AGT—dilated cardiomyopathy	6.82e-05	0.000289	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—CD36—dilated cardiomyopathy	6.62e-05	0.00028	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	6.62e-05	0.00028	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.43e-05	0.000272	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AGT—dilated cardiomyopathy	6.41e-05	0.000271	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	6.4e-05	0.000271	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—RAC1—dilated cardiomyopathy	6.24e-05	0.000264	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GPX1—dilated cardiomyopathy	6.21e-05	0.000263	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NPPA—dilated cardiomyopathy	6.21e-05	0.000263	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	6.19e-05	0.000262	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.14e-05	0.00026	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CD36—dilated cardiomyopathy	6.05e-05	0.000256	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	6.02e-05	0.000255	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PSEN2—dilated cardiomyopathy	6.01e-05	0.000254	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	5.98e-05	0.000253	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.82e-05	0.000246	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GPX1—dilated cardiomyopathy	5.8e-05	0.000245	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CD36—dilated cardiomyopathy	5.64e-05	0.000239	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.45e-05	0.000231	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AGT—dilated cardiomyopathy	5.45e-05	0.000231	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	5.44e-05	0.00023	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—RAF1—dilated cardiomyopathy	5.33e-05	0.000226	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.27e-05	0.000223	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.19e-05	0.00022	CbGpPWpGaD
Doxorubicin—NOS1—Disease—RAC1—dilated cardiomyopathy	5.16e-05	0.000218	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.12e-05	0.000217	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.12e-05	0.000217	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AGT—dilated cardiomyopathy	5.08e-05	0.000215	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.02e-05	0.000213	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5e-05	0.000212	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.98e-05	0.000211	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.89e-05	0.000207	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.82e-05	0.000204	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.76e-05	0.000202	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	4.69e-05	0.000199	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.69e-05	0.000199	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.52e-05	0.000191	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.42e-05	0.000187	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.42e-05	0.000187	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	4.41e-05	0.000187	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.4e-05	0.000186	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AGT—dilated cardiomyopathy	4.32e-05	0.000183	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.22e-05	0.000179	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.21e-05	0.000178	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.17e-05	0.000177	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—RAF1—dilated cardiomyopathy	4.14e-05	0.000175	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.11e-05	0.000174	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.02e-05	0.00017	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	3.99e-05	0.000169	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.98e-05	0.000169	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.95e-05	0.000167	CbGpPWpGaD
Doxorubicin—NOS2—Disease—RAC1—dilated cardiomyopathy	3.89e-05	0.000165	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NPPA—dilated cardiomyopathy	3.78e-05	0.00016	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.77e-05	0.00016	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.74e-05	0.000158	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.74e-05	0.000158	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.68e-05	0.000156	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PSEN2—dilated cardiomyopathy	3.66e-05	0.000155	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.65e-05	0.000155	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—RAC1—dilated cardiomyopathy	3.58e-05	0.000151	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.55e-05	0.00015	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.47e-05	0.000147	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.46e-05	0.000147	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.46e-05	0.000147	CbGpPWpGaD
Doxorubicin—NOS1—Disease—RAF1—dilated cardiomyopathy	3.42e-05	0.000145	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.4e-05	0.000144	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GPX1—dilated cardiomyopathy	3.38e-05	0.000143	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.36e-05	0.000142	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.31e-05	0.00014	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CD36—dilated cardiomyopathy	3.29e-05	0.000139	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GPX1—dilated cardiomyopathy	3.26e-05	0.000138	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	3.26e-05	0.000138	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.25e-05	0.000138	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.23e-05	0.000137	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.2e-05	0.000135	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CD36—dilated cardiomyopathy	3.18e-05	0.000135	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	3.07e-05	0.00013	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GPX1—dilated cardiomyopathy	3.03e-05	0.000128	CbGpPWpGaD
Doxorubicin—NOS3—Disease—RAC1—dilated cardiomyopathy	3.02e-05	0.000128	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RAF1—dilated cardiomyopathy	3e-05	0.000127	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AGT—dilated cardiomyopathy	2.97e-05	0.000126	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CD36—dilated cardiomyopathy	2.96e-05	0.000125	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.94e-05	0.000125	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.87e-05	0.000122	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AGT—dilated cardiomyopathy	2.86e-05	0.000121	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.79e-05	0.000118	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.77e-05	0.000117	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.77e-05	0.000117	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GPX1—dilated cardiomyopathy	2.76e-05	0.000117	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.73e-05	0.000115	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CD36—dilated cardiomyopathy	2.69e-05	0.000114	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AGT—dilated cardiomyopathy	2.66e-05	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.62e-05	0.000111	CbGpPWpGaD
Doxorubicin—NOS2—Disease—RAF1—dilated cardiomyopathy	2.58e-05	0.000109	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.5e-05	0.000106	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AGT—dilated cardiomyopathy	2.42e-05	0.000102	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AGT—dilated cardiomyopathy	2.39e-05	0.000101	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—RAF1—dilated cardiomyopathy	2.37e-05	0.0001	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EGFR—dilated cardiomyopathy	2.35e-05	9.93e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.34e-05	9.92e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GPX1—dilated cardiomyopathy	2.24e-05	9.47e-05	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.21e-05	9.35e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.18e-05	9.24e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CD36—dilated cardiomyopathy	2.18e-05	9.22e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	2.14e-05	9.08e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.13e-05	9.03e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RAC1—dilated cardiomyopathy	2.12e-05	8.96e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CD36—dilated cardiomyopathy	2.09e-05	8.84e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.06e-05	8.7e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AGT—dilated cardiomyopathy	2.02e-05	8.56e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.01e-05	8.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—RAF1—dilated cardiomyopathy	2e-05	8.48e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AGT—dilated cardiomyopathy	1.96e-05	8.3e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.92e-05	8.13e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AGT—dilated cardiomyopathy	1.88e-05	7.96e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RAC1—dilated cardiomyopathy	1.84e-05	7.8e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.81e-05	7.68e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.79e-05	7.59e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—dilated cardiomyopathy	1.77e-05	7.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.71e-05	7.23e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	1.68e-05	7.11e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.66e-05	7.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CD36—dilated cardiomyopathy	1.64e-05	6.93e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—dilated cardiomyopathy	1.63e-05	6.89e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	1.63e-05	6.88e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	1.58e-05	6.7e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.48e-05	6.26e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AGT—dilated cardiomyopathy	1.47e-05	6.24e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.44e-05	6.1e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	1.43e-05	6.03e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.4e-05	5.94e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—dilated cardiomyopathy	1.37e-05	5.82e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AGT—dilated cardiomyopathy	1.3e-05	5.49e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RAF1—dilated cardiomyopathy	1.22e-05	5.17e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.14e-05	4.82e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.08e-05	4.59e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.06e-05	4.47e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.04e-05	4.4e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—dilated cardiomyopathy	9.62e-06	4.07e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	9.51e-06	4.02e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—dilated cardiomyopathy	8.37e-06	3.54e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	8e-06	3.38e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.79e-06	3.3e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	7.53e-06	3.19e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	7.34e-06	3.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	7.01e-06	2.97e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	6.61e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.93e-06	2.09e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.8e-06	2.03e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.32e-06	1.83e-05	CbGpPWpGaD
